Drug Type Small molecule drug |
Synonyms JNJ 17166864 |
Target |
Action antagonists |
Mechanism CCR2 antagonists(C-C chemokine receptor type 2 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC21H25Cl3N2O2 |
InChIKeyVALRCWBOFWDEDE-UHFFFAOYSA-N |
CAS Registry874887-03-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Rhinitis, Allergic, Seasonal | Phase 2 | United States | 01 Jan 2008 |





